NAVLE Respiratory

Bovine Tuberculosis Study Guide

📅 March 28, 2026 ⏱ 25 min read 👁 1 views

Bovine tuberculosis (bTB) is a chronic, infectious, granulomatous disease caused by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex (MTBC).

Overview and Clinical Importance

Bovine tuberculosis (bTB) is a chronic, infectious, granulomatous disease caused by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex (MTBC). This disease represents a significant zoonotic concern and has major implications for public health, international trade, and herd management. The NAVLE frequently tests on bTB due to its regulatory importance, diagnostic challenges, and public health implications.

Understanding bTB is essential because it is a notifiable disease in most countries, requires mandatory testing for interstate and international movement of cattle, and has been the focus of eradication programs since 1917 in the United States. Despite near-eradication in developed countries, wildlife reservoirs (white-tailed deer, badgers, possums) continue to pose challenges for complete elimination.

High-YieldOn the NAVLE, remember that bovine TB is primarily transmitted via aerosol inhalation, causes characteristic granulomatous lesions (tubercles), and is diagnosed using the tuberculin skin test (caudal fold test) as the primary screening method. Treatment is NOT permitted in food-producing animals - test-and-slaughter is the mandatory control approach.

Characteristic	Description
Morphology	Straight or slightly curved rod-shaped bacilli, 1-4 micrometers long by 0.2-0.3 micrometers wide
Staining	Acid-fast positive (Ziehl-Neelsen stain); appears red/pink against blue background
Growth	Slow-growing (16-20 hour generation time); obligate aerobe; requires 3-8 weeks for visible colonies
Cell Wall	High lipid content (60%), particularly mycolic acids; provides resistance to desiccation and disinfectants
Environmental Survival	Survives 6+ months in slurry/soil; resistant to freezing; killed at 65 degrees C for 30 minutes or by UV light
Drug Resistance	Naturally resistant to pyrazinamide (unlike M. tuberculosis); sensitive to TCH and INH

Etiology

Causative Agent

Mycobacterium bovis is the primary etiological agent of bovine tuberculosis. Key characteristics include:

Route	Mechanism	Clinical Significance
Aerosol (Primary)	Inhalation of respiratory droplets from infected animals; close contact in barns	Results in pulmonary and thoracic lymph node lesions; most common route
Ingestion	Contaminated feed, water, milk, or pasture; calves nursing infected dams	Results in mesenteric lymph node and intestinal lesions
Congenital	In utero transmission from infected dam	Rare; results in generalized infection in neonates
Direct Contact	Wound contamination; venereal (rare)	Uncommon; seen in slaughterhouse workers (zoonotic)

Transmission and Epidemiology

Routes of Transmission

Susceptible Species and Wildlife Reservoirs

While cattle are the primary hosts, M. bovis has a remarkably wide host range including:

Domestic animals: bison, buffalo, goats, sheep, pigs, llamas, alpacas, cats, dogs
Wildlife reservoirs (critical for eradication): white-tailed deer (Michigan, USA), European badgers (UK), brushtail possums (New Zealand), African buffalo (South Africa)
Humans: zoonotic transmission primarily through unpasteurized dairy products or occupational exposure

NAVLE TipWhen the NAVLE asks about wildlife reservoirs complicating bTB eradication, think WHITE-TAILED DEER in Michigan (USA) and BADGERS in the UK. These maintenance hosts perpetuate infection despite cattle testing programs.

Stage	Histological Features
Stage I (Initial)	Accumulation of epithelioid macrophages, lymphocytes, neutrophils; Langhans-type multinucleated giant cells present
Stage II (Solid)	Central infiltrates of neutrophils and lymphocytes; thin fibrous capsule forming
Stage III (Necrotic)	Complete fibrous encapsulation; significant central caseous necrosis with little mineralization
Stage IV (Calcified)	Multiple coalescing caseonecrotic granulomas; multicentric necrosis with CALCIFICATION; thick fibrous capsule

Pathogenesis

Mechanism of Disease

The pathogenesis of bovine tuberculosis involves a complex interplay between the organism and host immune response. Following inhalation or ingestion of M. bovis, the following sequence occurs:

Initial Infection: Bacteria are phagocytosed by alveolar macrophages but resist intracellular killing due to mycolic acid-rich cell wall
Survival and Replication: M. bovis inhibits phagosome-lysosome fusion and multiplies within macrophages
Cell-Mediated Immunity (CMI): T-lymphocytes (CD4+) release interferon-gamma (IFN-gamma), activating macrophages; this response forms the basis for tuberculin testing
Granuloma Formation: Epithelioid macrophages, lymphocytes, and Langhans multinucleated giant cells form characteristic TUBERCLES
Caseous Necrosis: Central necrosis occurs within granulomas, producing characteristic cheese-like (caseous) material with or without calcification

Granuloma Staging (Histopathological Classification)

System/Sign	Clinical Presentation
General	Progressive emaciation despite normal/capricious appetite; weakness; low-grade fluctuating fever
Respiratory	Chronic moist cough (intermittent); dyspnea; tachypnea; abnormal lung sounds on auscultation
Lymph Nodes	Enlargement of superficial lymph nodes (retropharyngeal, prescapular, prefemoral); may cause obstruction (airways, pharynx)
Mammary	Chronic mastitis (rare); supramammary lymph node enlargement; shedding in milk
Reproductive	Reduced fertility; infertility in advanced cases
Terminal	Severe cachexia; respiratory distress; death usually within 1-2 weeks after onset of severe clinical signs

Clinical Signs

Critical Point: Approximately 90% of infected cattle are clinically ASYMPTOMATIC. The disease has a prolonged course, and clinical signs typically take months to years to develop. Most infected animals are identified through routine testing programs or slaughterhouse surveillance, NOT clinical examination.

When Clinical Signs Are Present

High-YieldA classic NAVLE presentation is a cow with progressive weight loss DESPITE a normal appetite, combined with a chronic moist cough. However, remember most cases are subclinical and detected only through testing.

Location	Frequency	Notes
Bronchial/Mediastinal LN	Most common	Primary inspection site at slaughter
Retropharyngeal LN	Very common	Head lymph node; aerosol route
Lungs	Common	Granulomatous bronchopneumonia; miliary pattern possible
Mesenteric LN	Moderate	Indicates oral route of infection
Liver/Spleen	Less common	Indicates disseminated/generalized infection
Pleura/Peritoneum	Variable	'Pearl disease' - grape-like clusters on serous membranes

Pathological Findings

Gross Pathology

The hallmark lesion of bovine TB is the TUBERCLE - a granulomatous nodule with the following characteristics:

Appearance: Yellow-orange to gray nodules; variable size (1 mm to several cm)
Texture: Caseous (cheese-like) center; may be calcified (gritty on cut surface)
Encapsulation: Surrounded by fibrous connective tissue capsule
Pattern: May coalesce to form larger masses; 'grape-like' clusters on pleura (pearl disease)

Lesion Distribution by Site

Parameter	Details
Injection Site	Caudal fold of the tail (2-3 inches from tail base); intradermal injection
Antigen	Bovine PPD (purified protein derivative); 0.1 mL intradermal
Reading Time	72 hours post-injection (acceptable range: 66-78 hours)
Positive Result	ANY palpable swelling or increase in skin thickness at injection site
Sensitivity	80-95% (varies with stage of infection)
Specificity	96-99%; false positive rate of 1-5% expected

Diagnosis

Antemortem Diagnostic Tests

Caudal Fold Tuberculin Test (CFT) - Primary Screening Test

The CFT is the official screening test for bovine TB in the United States and many other countries. It detects delayed-type hypersensitivity (Type IV) to mycobacterial antigens.

High-YieldCFT RESPONDERS (positive on screening) require follow-up with the Comparative Cervical Test (CCT) or gamma-interferon assay. A single positive CFT does NOT confirm bTB infection - it identifies animals requiring further testing.

Comparative Cervical Test (CCT) - Confirmatory Test

The CCT is used as a secondary/confirmatory test for CFT responders. It differentiates M. bovis infection from cross-reactions with other mycobacteria (M. avium, M. paratuberculosis).

Injection Sites: Two sites in the cervical (neck) region, 12-15 cm apart
Antigens: Bovine PPD at one site; Avian PPD at the other site
Reading: 72 hours; measure skin thickness increase at both sites
Interpretation: Results plotted on scattergram; bovine response greater than 4mm more than avian = REACTOR
Timing: Must be performed within 10 days of CFT OR after 60 days

Gamma-Interferon (IFN-gamma) Assay

The BOVIGAM test is a blood-based assay that measures cell-mediated immune response to M. bovis antigens:

Principle: Whole blood incubated with bovine and avian PPD; IFN-gamma production measured by ELISA
Advantages: Detects infection earlier than skin test; single visit; results in 24-48 hours
Sensitivity: 81-100% for culture-confirmed cases
Specificity: 94-100%
Limitation: Blood must be processed within 8-24 hours of collection; NOT approved for bison or cervids

Diagnostic Test Comparison Summary

Postmortem Diagnosis

Definitive diagnosis requires bacterial culture and identification. Postmortem methods include:

Gross Examination: Inspection of lymph nodes (head, thorax, mesenteric) and organs for tuberculous lesions
Histopathology: Characteristic granulomatous inflammation with caseous necrosis, epithelioid macrophages, Langhans giant cells
Acid-Fast Staining (Ziehl-Neelsen): Red/pink rod-shaped bacteria against blue background; may be paucibacillary (few organisms)
Culture: Gold standard; requires 3-8 weeks on specialized media (Lowenstein-Jensen, Middlebrook 7H10/7H11)
PCR: Rapid detection of M. tuberculosis complex DNA; useful for confirmation

Causes of False Test Results

Test	Type	Use	Key Points
CFT	Screening	Primary test	Caudal fold; any response = suspect
CCT	Confirmatory	Follow-up for CFT+	Cervical; compares bovine vs avian
IFN-gamma	Supplemental	Parallel with skin test	Blood test; early detection

Control and Eradication

Key Principles

CRITICAL: Treatment of bovine TB is PROHIBITED in food-producing animals. Control relies entirely on test-and-slaughter programs and surveillance.

NAVLE TipRemember: No treatment, No vaccination (interferes with testing), Test-and-Slaughter ONLY. When the NAVLE presents a scenario involving a TB reactor, the correct answer involves slaughter - not treatment or isolation.

False Negatives	False Positives
Early infection (less than 3-6 weeks)	M. avium (avian TB) infection
Advanced/anergic disease	M. avium subsp. paratuberculosis (Johne's)
Recent calving (periparturient)	Environmental/saprophytic mycobacteria
Immunosuppression	M. kansasii infection
Old age	Improper test technique

Zoonotic Potential and Public Health

M. bovis is a significant ZOONOTIC pathogen that causes tuberculosis in humans indistinguishable from M. tuberculosis infection. Globally, an estimated 142,000 new cases and 12,500 deaths from zoonotic TB occur annually.

Control Measure	Implementation
Test-and-Slaughter	Mandatory slaughter of reactor animals; whole herd testing every 60 days until 2 consecutive negative tests
Slaughter Surveillance	Inspection of all slaughtered cattle for suspicious lesions; traceback investigation to herd of origin
Movement Restrictions	Quarantine of affected herds; testing required for interstate/international movement
Herd Depopulation	Complete herd removal may be recommended in heavily infected herds; indemnity payment to owners
Premises Disinfection	Cleaning and disinfection within 15-30 days of removing infected animals; M. bovis killed by 5% phenol, formaldehyde, chlorine compounds
Milk Pasteurization	Destroys M. bovis; eliminated zoonotic transmission via dairy products in developed countries

Memory Aids for NAVLE

Mnemonic: 'TUBERCLE' for Key Features

T - Test with CFT (caudal fold tuberculin test)

U - Unpasteurized milk = zoonotic risk

B - Bronchial/mediastinal lymph nodes (primary site)

E - Eradication via test-and-slaughter (no treatment)

R - Read at 72 hours post-injection

C - Caseous necrosis and calcification

L - Langhans giant cells (pathognomonic)

E - Emaciation with normal appetite (classic clinical sign)

Quick Facts to Remember

90% of infected cattle are ASYMPTOMATIC
CFT read at 72 hours; ANY response = suspect
CCT: Bovine minus Avian greater than 4mm = REACTOR
M. bovis is resistant to PYRAZINAMIDE (unlike M. tuberculosis)
Wildlife reservoirs: Deer (US), Badgers (UK), Possums (NZ)
Ziehl-Neelsen stain: RED bacilli on BLUE background

Aspect	Details
Transmission Routes	Unpasteurized dairy products (primary historical route); aerosol from infected animals; wound contamination during slaughter/hunting
At-Risk Populations	Farm workers, veterinarians, slaughterhouse workers, hunters, consumers of raw milk products, immunocompromised individuals
Clinical Presentation	Often extrapulmonary (cervical/mesenteric lymphadenopathy); pulmonary TB indistinguishable from M. tuberculosis
Treatment Note	M. bovis is naturally RESISTANT to pyrazinamide (first-line TB drug); requires modified treatment regimen

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →